Material-based regulation of the myofibroblast phenotype

Biomaterials

Volumn 28, Issue 23, 2007, Pages 3378-3387

  Cushing, Melinda C ^a   Liao, Jo Tsu ^a   Jaeggli, Michael P ^b   Anseth, Kristi S ^a,b  

^a UCB 450   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Cardiac valve tissue engineering; Cell signalling; Fibroblast growth factor receptor; Heparin; Hydrogel; MAPK

Indexed keywords

BIOACTIVITY; CELL GROWTH; COLLAGEN; ENZYME INHIBITION; FIBROBLASTS; HYDROGELS;

CARDIAC VALVE TISSUE ENGINEERING; CELL SIGNALLING; FIBROBLAST GROWTH FACTOR RECEPTOR; HEPARIN;

GENES;

ALPHA SMOOTH MUSCLE ACTIN; ARGINYLGLYCYLASPARTYLSERINE; BIOMATERIAL; COLLAGEN; FIBROBLAST GROWTH FACTOR 2; GLYCOSAMINOGLYCAN; GROWTH FACTOR RECEPTOR; HEPARIN; MITOGEN ACTIVATED PROTEIN KINASE; VINYL DERIVATIVE;

ANIMAL CELL; ARTICLE; CELL FUNCTION; CELL SURFACE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; GEL; HEART VALVE; HYDROGEL; LEYDIG CELL; MYOFIBROBLAST; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SERUM; TISSUE ENGINEERING;

ACTINS; ANIMALS; AORTIC VALVE; BIOCOMPATIBLE MATERIALS; CELLS, CULTURED; COLLAGEN; CULTURE MEDIA, SERUM-FREE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; FIBROBLAST GROWTH FACTOR 2; FIBROBLASTS; GENE EXPRESSION REGULATION; HEPARAN SULFATE PROTEOGLYCANS; HEPARIN; HYDROGEL; MITOGEN-ACTIVATED PROTEIN KINASES; MODELS, BIOLOGICAL; MUSCLE, SMOOTH; PHENOTYPE; RECEPTORS, FIBROBLAST GROWTH FACTOR; SIGNAL TRANSDUCTION; SUBSTRATE SPECIFICITY; SWINE; TISSUE ENGINEERING;

EID: 34248348771     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2007.04.005     Document Type: Article

References (38)

1. Majno G., Gabbiani G., Hirschel B.J., Ryan G.B., and Statkov P.R. Contraction of granulation tissue in vitro: similarity to smooth muscle. Science 173 (1971) 548-550
2. Gabbiani G. The myofibroblast in wound healing and fibrocontractive diseases. J Pathol 200 (2003) 500-503
3. Walker G.A., Masters K.S., Shah D.N., Anseth K.S., and Leinwand L.A. Valvular myofibroblast activation by transforming growth factor-beta. Circ Res 95 (2004) 253-260
4. Mattey D.L., Dawes P.T., Nixon N.B., and Slater H. Transforming growth factor beta 1 and interleukin 4 induced alpha smooth muscle actin expression and myofibroblast-like differentiation in human synovial fibroblasts in vitro: modulation by basic fibroblast growth factor. Ann Rheum Dis 56 (1997) 426-431
5. Kawai-Kowase K., et al. Basic fibroblast growth factor antagonizes transforming growth factor-{beta}1-induced Smooth muscle gene expression through extracellular signal-regulated kinase 1/2 signaling pathway activation. Arterioscler Thromb Vasc Biol 24 (2004) 1384-1390
6. Greenberg R.S., et al. FAK-dependent regulation of myofibroblast differentiation. Faseb J 20 (2006) 1006-1008
7. Cushing MC. Thesis Dissertation, Chapter 7, University of Colorado 2006.
8. Hacker U., Nybakken K., and Perrimon N. Heparan sulphate proteoglycans: the sweet side of development. Nat Rev Mol Cell Biol 6 (2005) 530-541
9. Rapraeger A.C., Krufka A., and Olwin B.B. Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. Science 252 (1991) 1705-1708
10. Kan M., et al. An essential heparin-binding domain in the fibroblast growth factor receptor kinase. Science 259 (1993) 1918-1921
11. Quarto N., and Amalric F. Heparan sulfate proteoglycans as transducers of FGF-2 signalling. J Cell Sci 107 (1994) 3201-3212
12. Goldfarb M. Signaling by fibroblast growth factors: the inside story. Sci STKE 2001 (2001) pe37
13. Reiland J., and Rapraeger A.C. Heparan sulfate proteoglycan and FGF receptor target basic FGF to different intracellular destinations. J Cell Sci 105 Pt 4 (1993) 1085-1093
14. Tsang M., and Dawid I.B. Promotion and attenuation of FGF signaling through the Ras-MAPK pathway. Sci STKE 2004 (2004) pe17
15. Johnson C., Hanson M., and Helgeson S. Porcine cardiac valvular subendothelial cells in culture: cell isolation and growth characteristics. J Mol Cell Cardiol 19 12 (1987) 1185-1193
16. Keller K.M., Brauer P.R., and Keller J.M. Modulation of cell surface heparan sulfate structure by growth of cells in the presence of chlorate. Biochemistry 28 (1989) 8100-8107
17. Smeds K.A., and Grinstaff M.W. Photocrosslinkable polysaccharides for in situ hydrogel formation (vol. 54, p. 115, 2000). J Biomed Mater Res 55 (2001) 254-255
18. Benoit D.S., and Anseth K.S. Heparin functionalized PEG gels that modulate protein adsorption for hMSC adhesion and differentiation. Acta Biomater. 1 (2005) 461-470
19. Sawhney A.S., Pathak C.P., and Hubbell J.A. Bioerodible hydrogels based on photopolymerized poly(ethylene glycol)-co-poly(a-hydroxy acid) diacrylate macromers. Macromolecules 26 (1993) 581-587
20. Masters K.S., Shah D.N., Walker G., Leinwand L.A., and Anseth K.S. Designing scaffolds for valvular interstitial cells: cell adhesion and function on naturally derived materials. J Biomed Mater Res 71A (2004) 172-180
21. Rydholm A.E., Reddy S.K., Anseth K.S., and Bowman C.N. Controlling network structure in degradable thiol-acrylate biomaterials to tune mass loss behavior. Biomacromolecules 7 (2006) 2827-2836
22. Abramoff M.D., Magelhaes P.J., and Ram S.J. Image processing with image. J Biophoton Int 11 (2004) 36-42
23. Krufka A., Guimond S., and Rapraeger A.C. Two hierarchies of FGF-2 signaling in heparin: mitogenic stimulation and high-affinity binding/receptor transphosphorylation. Biochemistry 35 (1996) 11131-11141
24. Fannon M., Forsten K.E., and Nugent M.A. Potentiation and inhibition of bFGF binding by heparin: a model for regulation of cellular response. Biochemistry 39 (2000) 1434-1445
25. Johnson G.L., and Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298 (2002) 1911-1912
26. Esch F., et al. Primary structure of bovine pituitary basic fibroblast growth factor (FGF) and comparison with the amino-terminal sequence of bovine brain acidic FGF. Proc Natl Acad Sci USA 82 (1985) 6507-6511
27. Ronnov-Jessen L., and Petersen O.W. Induction of alpha-smooth muscle actin by transforming growth factor-beta 1 in quiescent human breast gland fibroblasts. Implications for myofibroblast generation in breast neoplasia. Lab Invest 68 (1993) 696-707
28. Maltseva O., Folger P., Zekaria D., Petridou S., and Masur S.K. Fibroblast growth factor reversal of the corneal myofibroblast phenotype. Invest Ophthalmol Vis Sci 42 (2001) 2490-2495
29. Khouw I.M.S.L., et al. TGF-[beta] and bFGF affect the differentiation of proliferating porcine fibroblasts into myofibroblasts in vitro. Biomaterials 20 (1999) 1815-1822
30. Verrecchia F., and Mauviel A. Transforming growth factor-beta signaling through the Smad pathway: role in extracellular matrix gene expression and regulation. J Invest Dermatol 118 (2002) 211-215
31. Tomasek J.J., Gabbiani G., Hinz B., Chaponnier C., and Brown R.A. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol 3 (2002) 349-363
32. McCaffrey T.A., Falcone D.J., and Du B.H. Transforming growth factor-beta-1 is a heparin-binding protein-identification of putative heparin-binding regions and isolation of heparins with varying affinity for Tgf-Beta-1. J Cell Physiol 152 (1992) 430-440
33. McCaffrey T.A., et al. Transforming growth factor-beta activity is potentiated by heparin via dissociation of the transforming growth factor-beta/alpha 2-macroglobulin inactive complex. J Cell Biol 109 (1989) 441-448
34. Lutolf M.P., and Hubbell J.A. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat Biotechnol 23 (2005) 47-55
35. Gotlieb A.I., Rosenthal A., and Kazemian P. Fibroblast growth factor 2 regulation of mitral valve interstitial cell repair in vitro. J Thorac Cardiovasc Surg 124 (2002) 591-597
36. Pike D.B., et al. Heparin-regulated release of growth factors in vitro and angiogenic response in vivo to implanted hyaluronan hydrogels containing VEGF and bFGF. Biomaterials 27 (2006) 5242-5251
37. Leicht M., et al. Mechanism of cell death of rat cardiac fibroblasts induced by serum depletion. Mol Cell Biochem 251 (2003) 119-126
38. Franco R., et al. Regulation of heptaspanning-membrane-receptor function by dimerization and clustering. Trends Biochem Sci 28 (2003) 238-243